Related Experiment Videos
Eye involvement in junctional epidermolysis bullosa
P J McDonnell1, O M Schofield, D J Spalton
1Department of Ophthalmology, United Medical School, St Thomas' Hospital, London, England.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|November 1, 1989
Summary
Ocular complications like recurrent corneal erosion and scarring are common in nonlethal junctional epidermolysis bullosa. Monoclonal antibody probes aid in understanding the basement membrane defect causing these eye issues.
Area of Science:
- Ophthalmology
- Genodermatoses
- Molecular Biology
Background:
- Junctional epidermolysis bullosa (JEB) is a rare genetic blistering skin disorder.
- The nonlethal form of JEB presents with significant ocular manifestations.
- Understanding the ocular pathology in JEB is crucial for patient management.
Purpose of the Study:
- To describe the ocular findings in patients with nonlethal junctional epidermolysis bullosa.
- To explore potential mechanisms underlying the ocular changes in JEB.
- To highlight the utility of monoclonal antibody probes in JEB research.
Main Methods:
- Clinical examination of ocular findings in five JEB patients.
- Review of patient history for recurrent corneal erosion and scarring.
- Discussion of pathomechanisms and application of basement membrane component analysis.
Main Results:
- Recurrent corneal erosion was a frequent finding in the studied patients.
- Corneal scarring was observed in the majority of patients.
- Monoclonal antibody probes are instrumental in identifying basement membrane defects.
Conclusions:
- Ocular complications are a significant feature of nonlethal JEB.
- Basement membrane abnormalities are implicated in the ocular pathology of JEB.
- Advanced molecular techniques offer insights into the fundamental defects of JEB.